C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.

Br J Cancer · 1990 · PMC1971341 · PMID 2153396

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

approached significanceP = 0.05actually significant

When these tamoxifen-treated patients were excluded from the disease recurrence study (Table I), the trend towards an association between c-erbB2 levels and relapse approached significance (P = 0.05-0.1).

also in 5,257 other papers

a definite trendno p-value reported

No significant correlation was observed between overexpression of c-erbB2 mRNA and early disease recurrence in our group of patients, although there was a definite trend towards poorer prognosis.

also in 240 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.